VVP
TECH icon

Venture Visionary Partners’s Bio-Techne TECH Stock Holding History

Venture Visionary Partners’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-104
Closed -$9.01K – 1425
2022
Q2 		$9.01K Buy
+104
New +$9.75K ﹤0.01% 1273

Other funds holding TECH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $29.1B AUM 43.86% 1-Year Est. Return

Venture Visionary Partners's TECH Position: Q3 2022 in Review

Venture Visionary Partners sold out of Bio-Techne (TECH) in Q3 2022, closing a stake of 104 shares — an estimated $9.01K sold.

Venture Visionary Partners first reported a position in TECH in Q2 2022 and held it in 1 quarter. The position peaked at $9.01K in Q2 2022. 536 funds tracked by Wall St. Rank hold TECH as of Q3 2022.

  • Venture Visionary Partners reported no remaining Bio-Techne position as of Q3 2022 after selling out during the quarter.
  • Venture Visionary Partners sold 104 Bio-Techne shares in Q3 2022, an estimated $9.01K.
  • Venture Visionary Partners first reported a position in Bio-Techne in Q2 2022 and held it in 1 quarter.
  • Venture Visionary Partners's Bio-Techne position peaked at $9.01K in Q2 2022.
  • 536 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2022.

Based on Venture Visionary Partners's 13F filing for Q3 2022, filed 14 Nov 2022.